MBOT
NASDAQ
Health Care
$1.75
USD
-$0.04 (-2.23%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$119.89M
Volume:
743.6K
Previous Close
$1.79
Day Range
$1.74 - $1.79
52 Week Range
$1.60 - $4.67
Average Volume (10 Days)
620.0K
P/E Ratio (TTM)
—
Dividend Yield
—
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 43 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
CEO
Mr. Harel Gadot
Headquaters
Hingham, MASSACHUSETTS, US
Founded
1992
Employees
43
GUTS
Fractyl Health Inc
$0.8100
-5.2%
HYPR
Hyperfine Inc
$0.9300
-5.2%